Obstruction of governmental medical reform

The pharmaceutical and medical industries attempt to hinder the reform of laws for testing drugs and medical products, such as blood, so that they may continue to deliver the same products as previously. Having to upgrade products would cut into their profits, they claim.

1. In 1995 in the USA, the medical industry paid large sums of money to finance politicians' electoral campaigns. These politicians, once elected, then came under pressure from the industry to pass legislature that requires the government to conduct exhaustive cost-benefit analyses before declaring drugs or food to be unsafe. This prevents or delays the removal of old unsafe drugs from the market, and protects the medical companies' profits.

1. Obstruction of administration of justice by undue influence
2. Hindrance of law enforcement
3. Corporate self interest overriding community
4. Commercial erosion of standards of quality

1. Ineffective monitoring
2. Inadequacy of governmental decision-making machinery
3. Erosion of regulatory provisions

1. Lack of social accounting in the business community
2. Ineffective self-regulation in the pharmaceutical and medical devices industries
3. Ineffective self-regulation in the health care sector
4. Commercial disregard of social responsibility

1. Reform
2. Obstruction
3. Counter-reformation